A Way Forward for Cancer Chemoprevention: Think Local
- PMID: 27780807
- DOI: 10.1158/1940-6207.CAPR-16-0194
A Way Forward for Cancer Chemoprevention: Think Local
Abstract
As cells progress through carcinogenesis, the associated exponential expansion of genetic and molecular aberrations and resultant heterogeneity make therapeutic success increasingly unattainable. Therapeutic intervention at early stages of carcinogenesis that occurs within the primary organ and in the face of a lower burden of molecular aberrations, constitutes a basic tenet of cancer chemoprevention, and provides a situation that favors a greater degree of therapeutic efficacy compared with that of advanced cancer. A longstanding barrier to chemoprevention relates to the requirement for essentially no systemic toxicity, and the fact that when large numbers of people are treated, the emergence of systemic toxicity is almost universal. A rational means to address this in fact relates to a second basic tenet of the chemopreventive strategy: the focus of therapeutic intervention is to disrupt a process that is in essence localized to a single organ. Based upon this consideration, a strategy which is based upon local delivery of therapeutics to an at-risk organ will achieve therapeutic efficacy while avoiding systemic delivery and its associated toxicity. This article will review the rationale for undertaking such an approach, describe successful clinical achievements based on this strategy, describe ongoing efforts to expand the impact of this approach, and together will highlight the high impact that this approach has already had on the field as well as its extremely high potential for future impact. Cancer Prev Res; 10(1); 14-35. ©2016 AACR.
©2016 American Association for Cancer Research.
Similar articles
-
Cancer chemoprevention by natural products: how far have we come?Pharm Res. 2010 Jun;27(6):950-61. doi: 10.1007/s11095-010-0085-y. Epub 2010 Mar 18. Pharm Res. 2010. PMID: 20238150 Review.
-
Cancer chemoprevention: progress and promise.Eur J Cancer. 1999 Dec;35(13):1755-62. doi: 10.1016/s0959-8049(99)00164-1. Eur J Cancer. 1999. PMID: 10673988 Review.
-
Chemoprevention of skin cancer: current status and future prospects.Cancer Metastasis Rev. 2002;21(3-4):363-80. doi: 10.1023/a:1021275330385. Cancer Metastasis Rev. 2002. PMID: 12549772 Review.
-
Cancer chemoprevention. A new way to treat cancer before it happens.Prim Care. 1998 Jun;25(2):361-79. doi: 10.1016/s0095-4543(05)70069-5. Prim Care. 1998. PMID: 9628956 Review.
-
An overview of chemoprevention: current status and future prospects.Proc Soc Exp Biol Med. 1997 Nov;216(2):133-41. doi: 10.3181/00379727-216-44163. Proc Soc Exp Biol Med. 1997. PMID: 9349682 Review.
Cited by
-
Intranasal administration of resveratrol successfully prevents lung cancer in A/J mice.Sci Rep. 2018 Sep 24;8(1):14257. doi: 10.1038/s41598-018-32423-0. Sci Rep. 2018. PMID: 30250304 Free PMC article.
-
Chemoprevention of Colorectal Cancer.Gastroenterology. 2020 Jan;158(2):368-388. doi: 10.1053/j.gastro.2019.06.047. Epub 2019 Sep 26. Gastroenterology. 2020. PMID: 31563626 Free PMC article. Review.
-
Assessing the Current State of Lung Cancer Chemoprevention: A Comprehensive Overview.Cancers (Basel). 2020 May 17;12(5):1265. doi: 10.3390/cancers12051265. Cancers (Basel). 2020. PMID: 32429547 Free PMC article. Review.
-
Evaluation of the STAT3 inhibitor GLG‑302 for the prevention of estrogen receptor‑positive and ‑negative mammary cancers.Oncol Rep. 2019 Sep;42(3):1205-1213. doi: 10.3892/or.2019.7219. Epub 2019 Jul 4. Oncol Rep. 2019. PMID: 31322250 Free PMC article.
-
Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets.Pharmaceuticals (Basel). 2019 May 5;12(2):68. doi: 10.3390/ph12020068. Pharmaceuticals (Basel). 2019. PMID: 31060335 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials